Skip Navigation Bar
National Intitutes of Health
This finding aids platform will be replaced in Fall 2022. Please explore the new platform Beta soft release by visiting https://archivesspace.nlm.nih.gov

Robert M. Chanock Papers 1933-2008 (bulk 1950-2008)
search terms in context | full text File Size: 260 K bytes | Add this to my bookbag

Box | Folder Title
 
Research Contracts, 1952-2001 [subseries]:
 
Proposals, 1955-2001 [subseries]:
47 11
Unidentified, undated
47 12
Etiology of viral diarrheas - part III, undated
47 13
To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg, 1955
47 14
Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., c.1964
47 15
The isolation of viruses and viral subunits, 1964
47 16
Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures, c.1965
47 17
Studies on adenovirus vaccines, c.1965
47 18
Biochemical and immunologic investigations of neisseria meningitidis, 1965
47 19
Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae, 1965
47 20
To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . ., 1965
47 21
Concentration of human hepatitis virus (supplement to NIAID Support of Man program), 1966
47 22
Proposed vaccine studies, Kansas City, 1966
47 23
Respiratory virus vaccines, 1967
47 24
Tests in infants and children for antigenicity and effectiveness of inactivated vaccines, 1967
47 25
X-ray crystal structure of adenovirus coat protein, 1969
47 26
Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971
47 27
Studies on hemophilus influenzae b vaccine, c.1972
47 28
Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization, 1974
47 29
Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells, 1975
47 30
Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection, 1975
47 31
Protective efficacy of langat virus vaccines in mice - animal study proposal, 1997
47 32
Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal, 1999
47 33
Evaluation of chimeric TBEV/DEN4 virus vaccines in mice, 2001
47 34
Immunogenicity and protective efficacy of langat virus vaccines in mice, 2001
 
Reports, 1952-1998 [subseries]:
47 35-39
National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati, 1952-1956
47 40
Vaccine development program commitments, 1965
47 41
Respiratory vaccine development, 1966
47 42
Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory, 1967
47 43
NIAID Molecular Anatomy Program, 1967
47 44
Evaluation of a live type 4 adenovirus vaccine, 1967-1968
47 45
Acute infectious nonbacterial gastroenteritis, 1973
47 46
103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies, 1964-1965
47 47
6-61-03-032 - Studies on virus and rickettsial diseases, 1953
47 48
263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions, 1981
47 49
263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions, 1981
47 50
3A014501B71Q - Communicable diseases - immunology, c.1966
47 51
DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines, 1963
47 52
DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus, 1965
47 53
DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections, 1965
47 54
DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus, 1967
47 55
DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus, 1971
47 56
DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus, 1971
47 57
M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits, 1972
48 1
NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines, 1970
48 2
NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines, 1970
48 3
NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1969
48 4
NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines, 1971
48 5-6
NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children, 1971, 1973
48 7
N01-AI-01528 - New viruses in relation to clinical diseases, 1968-1972
48 8-9
N01-AI-02638 - Operation of a virus vaccine production laboratory, 1980-1981, 1983-1987
48 10
N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals, 1981
48 11-13
N01-AI-05057 - University of Puerto Rico, 1991-1992
48 14-15
N01-AI-05067 - Care and housing of AIDS research animals, 1990-1991
48 16
N01-AI-17757 - Children's Hospital, 1980-1981
48 17-19
N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults, 1972-1989
48 20
N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains, 1974
48 21
N01-AI-22508 - Clinical evaluation of influenza virus vaccines, 1974
48 22
N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . ., 1993-1994
49 1-2
N01-AI-32521 - Operation of a virus laboratory in support of LID, 1974-1990
49 3-4
N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity, 1978
49 5
N01-AI-42528 - Influenza research center, 1979
49 6
N01-AI-52565, 1985-1987
49 7-8
N01-AI-72535 - Establishment of an infectious enteric disease study, 1978-1979
49 9-10
N01-AI-82681 - Operation of an experimental virus vaccine production laboratory, 1988-1989
49 11
N01-AO-52703 - Care and housing of AIDS research animals, 1997-1998
49 12
N01-AO-52706 - Facility for non-human primates utilized in infectious disease research, 1998
49 13
PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture, 1966
49 14
PH-43-62-80 - Production of enterovirus antisera, 1965
49 15
PH-43-62-127 - Preparation of immune serum to enteroviruses, 1965
49 16
PH-43-62-129 - Standardization of picornavirus immune sera, 1965
49 17-26
PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine, 1962-1970
49 27-29
PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance, 1966-1968
49 30-32
PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines, 1966-1968
49 33
PH-43-62-839 - Preparation of mycoplasma antigene and antisera, 1965
49 34-35
PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children, 1968, 1970
49 36-38
PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population, 1966-1968
50 1-4
PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species, 1964-1966
50 5-6
PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses, 1965, 1967
50 7
PH-43-63-81 - Development, growth and characterization of virus induced tumor cells, 1967
50 8
PH-43-63-90 - Upper respiratory virus, 1965
50 9
PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory, 1966
50 10-11
PH-43-63-562 - Prevention of viral respiratory infections, 1964, 1968
50 12
PH-43-63-563 - Vaccine studies in a children's center, 1968
50 13
PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection, 1967
50 14-16
PH-43-63-582 - Respiratory disease vaccine, 1962-1967
50 17-18
PH-43-63-1128 - Surveillance of respiratory infections in an industrial population, 1966, 1968
50 19-20
PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population, 1967-1968
50 21
PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus, 1964
50 22
PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses, 1965
50 23
PH-43-63-1177 - Reference seeds for echo and coxsackieviruses, 1965
50 24
PH-43-64-529 - Preparation and development of viral reagents, 1965
50 25-27
PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis, 1966, 1968, 1972
50 28-29
PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine, 1966-1967
50 30-32
PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs, 1965-1967
50 33-34
PH-43-65-562 - Rhinovirus reference laboratory, 1966-1967
50 35-36
PH-43-65-563 - Studies of RSV vaccines, 1966-1967
50 37
PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents, 1968
50 38-40
PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections, 1966-1968
50 41
PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers, 1966
50 42-43
PH-43-66-93 - Rubella vaccine development, 1967-1968
50 44
PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines, 1967
50 45
PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines, 1968
50 46-47
PH-43-66-461 - Research and development of an inactivated rubella virus vaccine, 1967-1968
50 48
PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents, 1966
50 49
PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man, 1966-1968
50 50
PH-43-66-565 - Development of a live vaccine for human influenza, 1966
50 51-52
PH-43-66-917 - The role of infection in precipitating sudden deaths in infants, 1969
50 53-54
PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions, 1967-1968
50 55
PH-43-66-970 - Operation of a tissue culture developmental laboratory, 1967
50 56
PH-43-66-971 - Provide for the operation of a serology laboratory, 1967
50 57-58
PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children, 1968, 1970
50 59-60
PH-43-67-75 - The testing of rubella virus vaccines in human volunteers, 1967-1968
50 61
PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus, 1968
50 62
PH-43-67-77 - Biologic and antigenic studies with rubella virus, 1968
50 63
PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines, 1968
50 64-65
PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines, 1967
50 66
PH-43-67-80 - Studies of rubella vaccine efficacy, 1967
50 67
PH-43-67-91 - Research and development of respiratory disease vaccines, 1967-1968
50 68
PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines, 1973
50 69
PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis, 1969
50 70-71
PH-43-67-745 - Studies of local antibody in respiratory viral immunity, 1967, 1969
50 72
PH-43-68-81 - Operation of a rubella virus service laboratory, 1968
50 73
PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein, 1968
50 74
PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines, 1968
51 1-4
PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses, 1968-1975
51 5-6
PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness, 1968-1969
51 7
Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus, 1977
51 8
Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus, 1978-1981